
GXXY does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for GXXY and 80,000+ other tickers.
See exactly how GXXY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GXXY and 80,000+ other tickers.
Galexxy Holdings, Inc. operates as a key supplier within the agricultural sector. The company distinguishes itself by employing unique, proprietary systems and processes that efficiently optimize the use of critical resources – including water, energy, space, capital, and labor – to deliver essential fertilizers and nutrients. Their services are primarily targeted at specialized cultivation industries, with a significant focus on hemp. Its comprehensive product line encompasses a wide array of conventional and organic (non-GMO) fertilizers, vital nutrients, and crop protection solutions, such…

DANA POINT, CA / ACCESS Newswire / June 10, 2025 / Galexxy Holdings Inc. ("Galexxy" or "Company") (OTC:GXXY) is thrilled to announce a transformative partnership with New Age Marketing, a move designed to accelerate client acquisition and fuel sustainable growth for its innovative product line. In May 2024, Galexxy LLC and Galexxy Holdings Inc. formalized a Product and Brand Purchase Agreement, marking a significant milestone in the transfer of the Galexxy brand and its associated products.

PROVO, UT / ACCESSWIRE / June 25, 2024 / Announcing the launch of Adaptin, a new wellness brand extending the benefits of functional adaptogens and nootropics to consumers globally through new marketing pathways. The new company brings innovation to both the formulations and the way products are shared in the growing adaptogen and functional mushroom dietary supplements, valued in the US at USD $40B in 2023, and a part of the rapidly growing USD $5.7T global wellness market.

NEWPORT BEACH, CA / ACCESSWIRE / May 14, 2024 / Galexxy Holdings Inc., ("Galexxy") (OTC PINK:GXXY) today announced Tyler Whitehead, Co-Founder and CEO of Adaptin, LLC, former CEO of Arbonne and past President for Nu Skin Enterprises, Inc., has been elected to Galexxy's board of directors. Tyler has spent over 20 years as an executive with a significant track record of growth leading companies in the wellness verticals of beauty, personal care, and dietary supplements.

NEWPORT BEACH, CA / ACCESSWIRE / May 1, 2024 / Galexxy Holdings Inc. ("Galexxy" or "Company") (OTC PINK:GXXY) funds Adaptin, a new company in the expanding $5.6 trillion-dollar global wellness market. Galexxy Holdings, Inc. is pleased to announce the creation of a new company, Adaptin, LLC ("Adaptin").

NEWPORT BEACH, CA / ACCESSWIRE / February 14, 2024 / Galexxy Holdings Inc., ("Galexxy" or "Company") (OTC PINK:GXXY), is redirecting its resources and capital into the Functional Mushroom Market, through Galexxy LLC, and Wellbeing Farms. Galexxy Holdings, a player in diversified industries, has divested from the CBD and Hemp business to reshape its focus on emerging markets with substantial growth potential.